{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T03:50:07Z","timestamp":1784173807647,"version":"3.55.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032648","name":"Osteoporosis Foundation of New Mexico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jocd.2025.101628","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:16:29Z","timestamp":1758701789000},"page":"101628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proceedings of the 2025 Santa Fe Bone Symposium: Current concepts in the care of patients with osteoporosis, parathyroid disorders, and rare bone diseases"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-9587","authenticated-orcid":false,"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1570-2617","authenticated-orcid":false,"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouneh K.","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7827-0778","authenticated-orcid":false,"given":"Michael R.","family":"McClung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T.","family":"Rush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5070-5154","authenticated-orcid":false,"given":"S. Bobo","family":"Tanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jocd.2025.101628_bib0001","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2217\/17455057.2.6.825","article-title":"Proceedings of the Santa Fe Bone Symposium 2006","volume":"2","author":"Lewiecki","year":"2006","journal-title":"Women's Health"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0002","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jocd.2007.12.017","article-title":"Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007","volume":"11","author":"Lewiecki","year":"2008","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0003","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jocd.2009.02.002","article-title":"2008 Santa Fe Bone Symposium: update on osteoporosis","volume":"12","author":"Lewiecki","year":"2009","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2009.12.003","article-title":"2009 Santa Fe Bone Symposium","volume":"13","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2010.12.001","article-title":"Osteoporosis update from the 2010 Santa Fe Bone Symposium","volume":"14","author":"Lewiecki","year":"2010","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2011.11.004","article-title":"Proceedings of the 2011 Santa Fe Bone Symposium","volume":"15","author":"Lewiecki","year":"2012","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0007","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jocd.2013.01.001","article-title":"Osteoporosis Update From the 2012 Santa Fe Bone Symposium","volume":"16","author":"Lewiecki","year":"2013","journal-title":"J Clin Densitom"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0008","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jocd.2013.11.006","article-title":"Osteoporosis update: proceedings of the 2013 Santa Fe Bone Symposium","volume":"17","author":"Lewiecki","year":"2014","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/07435800.2015.1005746","article-title":"Update on osteoporosis from the 2014 Santa Fe Bone Symposium","volume":"40","author":"Lewiecki","year":"2015","journal-title":"Endocr Res"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocd.2015.11.003","article-title":"Proceedings of the 2015 Santa Fe Bone Symposium: clinical applications of scientific advances in osteoporosis and metabolic bone disease","volume":"19","author":"Lewiecki","year":"2016","journal-title":"J Clin Densitom"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0011","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jocd.2017.01.001","article-title":"Proceedings of the 2016 Santa Fe Bone Symposium: new concepts in the management of osteoporosis and metabolic bone diseases","volume":"20","author":"Lewiecki","year":"2017","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0012","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocd.2017.10.041","article-title":"Proceedings of the 2017 Santa Fe Bone Symposium: insights and emerging concepts in the management of osteoporosis","volume":"21","author":"Lewiecki","year":"2018","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2018.09.010","article-title":"Proceedings of the 2018 Santa Fe Bone Symposium: advances in the management of osteoporosis","volume":"22","author":"Lewiecki","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2025.101628_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocd.2019.09.006","article-title":"Proceedings of the 2019 Santa Fe Bone Symposium: new concepts in the care of osteoporosis and rare bone diseases","volume":"23","author":"Lewiecki","year":"2019","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jocd.2021.10.001","article-title":"Proceedings of the 2021 Santa Fe Bone Symposium: advances in the management of osteoporosis and metabolic bone diseases","volume":"25","author":"Lewiecki","year":"2022","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0016","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jocd.2022.10.002","article-title":"Proceedings of the 2022 Santa Fe Bone Symposium: current concepts in the care of patients with osteoporosis and metabolic bone diseases","volume":"25","author":"Lewiecki","year":"2022","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101432","article-title":"Proceedings of the 2023 Santa Fe Bone Symposium: progress and controversies in the management of patients with skeletal diseases","volume":"26","author":"Lewiecki","year":"2023","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101559","article-title":"Proceedings of the 2024 Santa Fe Bone Symposium: update on the management of osteoporosis and rare bone diseases","volume":"28","author":"Lewiecki","year":"2025","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.jocd.2025.101628_bib0019","series-title":"Highlights from the 2009 Santa Fe Bone Symposium","author":"Lewiecki","year":"2009"},{"key":"10.1016\/j.jocd.2025.101628_bib0020","series-title":"Highlights from the 2010 Santa Fe Bone Symposium","author":"Lewiecki","year":"2010"},{"key":"10.1016\/j.jocd.2025.101628_bib0021","series-title":"Highlights of the 2011 Santa Fe Bone Symposium","author":"Lewiecki","year":"2012"},{"key":"10.1016\/j.jocd.2025.101628_bib0022","unstructured":"Lewiecki E.M., Bilezikian J.P., Bonewald L.F., et al. 2013 Santa Fe Bone Symposium highlights 2013 9\/06\/2015. Available from: http:\/\/2013santafebonesymposium.com."},{"key":"10.1016\/j.jocd.2025.101628_bib0023","unstructured":"Lewiecki E.M., Bilezikian J.P., Binkley N., et al. 2014 Santa Fe Bone Symposium highlights 2014 9\/6\/2015. Available from: http:\/\/www.2014santafebonesymposium.com\/."},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0024","doi-asserted-by":"crossref","first-page":"ziae002","DOI":"10.1093\/jbmrpl\/ziae002","article-title":"Postfracture survival in a population-based study of adults aged >\/=66 yr: a call to action at hospital discharge","volume":"8","author":"Vincent","year":"2024","journal-title":"JBMR Plus"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-017-4345-0","article-title":"Hip fracture trends in the United States, 2002 to 2015","volume":"29","author":"Lewiecki","year":"2018","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0026","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","article-title":"The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group","volume":"25","author":"Siris","year":"2014","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0027","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1359\/jbmr.2002.17.7.1148","article-title":"Bone quality: getting closer to a definition","volume":"17","author":"Watts","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0028","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02058664","article-title":"Tetracycline-based histological analysis of bone remodeling","volume":"3","author":"Frost","year":"1969","journal-title":"Calcif Tissue Res"},{"key":"10.1016\/j.jocd.2025.101628_bib0029","article-title":"Utility of iliac crest tetracycline-labelled bone biopsy in osteoporosis and metabolic bone disease: an evaluation of 95 cases over a period of 25 years","volume":"19","author":"Colazo","year":"2023","journal-title":"Bone Rep"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0025-6196(12)65502-5","article-title":"Comparison of dual-energy x-ray absorptiometry and dual photon absorptiometry for bone mineral measurements of the lumbar spine","volume":"63","author":"Wahner","year":"1988","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2023.101435","article-title":"Executive summary of the 2023 adult position development conference of the international society for clinical densitometry: DXA reporting, follow-up BMD testing and trabecular bone score application and reporting","volume":"27","author":"Shuhart","year":"2024","journal-title":"J Clin Densitom"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0032","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff","year":"2022","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2025.101628_bib0033","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2017.06.002","article-title":"The history of bone densitometry","volume":"104","author":"Miller","year":"2017","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0034","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0846537120919627","article-title":"Bone mineral densitometry reporting: pearls and pitfalls","volume":"72","author":"Martineau","year":"2021","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0035","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jocd.2017.06.019","article-title":"Use of trabecular bone score (TBS) as a complementary approach to dual-energy X-ray absorptiometry (DXA) for fracture risk assessment in clinical practice","volume":"20","author":"Shevroja","year":"2017","journal-title":"J Clin Densitom"},{"issue":"12","key":"10.1016\/j.jocd.2025.101628_bib0036","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s00198-020-05576-w","article-title":"Frequency of normal bone measurement in postmenopausal women with fracture: a registry-based cohort study","volume":"31","author":"Binkley","year":"2020","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0037","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40520-024-02784-w","article-title":"Radiofrequency echographic multi spectrometry (REMS) in the diagnosis and management of osteoporosis: state of the art","volume":"36","author":"Fuggle","year":"2024","journal-title":"Aging Clin Exp Res"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0038","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00198-025-07529-7","article-title":"Optimizing region of interest size and placement for clinical opportunistic CT trabecular bone Hounsfield unit measurements","volume":"36","author":"Sobecki","year":"2025","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jocd.2025.101628_bib0039","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00198-020-05384-2","article-title":"Biomechanical Computed Tomography analysis (BCT) for clinical assessment of osteoporosis","volume":"31","author":"Keaveny","year":"2020","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0040","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1210\/clinem\/dgae703","article-title":"Associations of serum testosterone and SHBG with incident fractures in middle-aged to older men","volume":"110","author":"Grahnemo","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0041","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0042","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2308836","article-title":"Testosterone treatment and fractures in men with hypogonadism","volume":"390","author":"Snyder","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0043","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00198-024-07337-5","article-title":"Rationale for osteoporosis screening in men","volume":"36","author":"Narla","year":"2025","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.jocd.2025.101628_bib0044","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.mayocp.2018.06.024","article-title":"Limited osteoporosis screening effectiveness due to low treatment rates in a national sample of older men","volume":"93","author":"Colon-Emeric","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0045","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamainternmed.2025.4150","article-title":"Remote bone health service for osteoporosis screening in high-risk men: a cluster randomized clinical trial","volume":"185","author":"Colon-Emeric","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"18","key":"10.1016\/j.jocd.2025.101628_bib0046","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0047","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/jbmr\/zjae090","article-title":"Osteoporosis treatment prevents hip fracture similarly in both sexes: the FOCUS observational study","volume":"39","author":"Keaveny","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0048","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s40520-023-02478-9","article-title":"Efficacy of osteoporosis pharmacological treatments in men: a systematic review and meta-analysis","volume":"35","author":"Beaudart","year":"2023","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0049","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00198-022-06610-9","article-title":"Discontinuation of denosumab in men with prostate cancer","volume":"34","author":"Solling","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jocd.2025.101628_bib0050","series-title":"Osteoporosis in Men","author":"Adler","year":"2024"},{"issue":"6","key":"10.1016\/j.jocd.2025.101628_bib0051","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","article-title":"Age and bone mass as predictors of fracture in a prospective study","volume":"81","author":"Hui","year":"1988","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0052","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/jwh.2008.0887","article-title":"Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center","volume":"18","author":"Cohen","year":"2009","journal-title":"J Womens Health"},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0053","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archinte.165.5.561","article-title":"Medical findings in outpatients with anorexia nervosa","volume":"165","author":"Miller","year":"2005","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0054","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12018-019-09260-4","article-title":"Low bone mineral density in anorexia nervosa: treatments and challenges","volume":"17","author":"Fazeli","year":"2019","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ajcn\/84.4.698","article-title":"Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents","volume":"84","author":"Misra","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.jocd.2025.101628_bib0056","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jc.2005-2818","article-title":"Determinants of skeletal loss and recovery in anorexia nervosa","volume":"91","author":"Miller","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0057","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4088\/JCP.15m10393","article-title":"Recovery from anorexia nervosa and bulimia nervosa at 22-year follow-up","volume":"78","author":"Eddy","year":"2017","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0058","article-title":"Estrogen for the treatment of low bone mineral density in anorexia nervosa","volume":"7","author":"Thavaraputta","year":"2022","journal-title":"J Psychiatry Brain Sci"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0059","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jbmr.447","article-title":"Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa","volume":"26","author":"Misra","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0060","doi-asserted-by":"crossref","first-page":"e3540","DOI":"10.1210\/clinem\/dgaa489","article-title":"Effect of teriparatide on bone remodeling and density in premenopausal idiopathic osteoporosis: a phase II trial","volume":"105","author":"Cohen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0061","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/21556660.2019.1579728","article-title":"Challenges in osteoporosis awareness and management: results from a survey of US postmenopausal women","volume":"8","author":"Lewiecki","year":"2019","journal-title":"J Drug Assess"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0062","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2015-3156","article-title":"Underdiagnosis and undertreatment of osteoporosis: the battle to be won","volume":"101","author":"Miller","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0063","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0826","article-title":"Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis","volume":"1","author":"Desai","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0064","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0065","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1210\/clinem\/dgae840","article-title":"Trends in osteoporosis drug therapy receipt among commercial and medicare advantage enrollees in the United States, 2011-2022","volume":"110","author":"Everhart","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0066","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0067","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","article-title":"Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS","volume":"107","author":"Anastasilakis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.jocd.2025.101628_bib0068","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0069","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jbmr.4434","article-title":"The interaction of acute-phase reaction and efficacy for osteoporosis after zoledronic acid: HORIZON pivotal fracture trial","volume":"37","author":"Black","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0070","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1007\/s00198-022-06493-w","article-title":"Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate","volume":"33","author":"Lu","year":"2022","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.jocd.2025.101628_bib0071","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0072","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz322","article-title":"Risk for infections during treatment with denosumab for osteoporosis: a systematic review and meta-analysis","volume":"105","author":"Diker-Cohen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jocd.2025.101628_bib0073","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"issue":"19","key":"10.1016\/j.jocd.2025.101628_bib0074","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0076","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10665","article-title":"Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates","volume":"6","author":"Krege","year":"2022","journal-title":"JBMR Plus"},{"issue":"16","key":"10.1016\/j.jocd.2025.101628_bib0077","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.jocd.2025.101628_bib0078","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jocd.2025.101628_bib0079","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit Kremers","year":"2015","journal-title":"J Bone Jt Surg Am"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3899\/jrheum.170990","article-title":"Rates of total joint replacement in the United States: future projections to 2020-2040 using the national inpatient sample","volume":"46","author":"Singh","year":"2019","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jocd.2025.101628_bib0081","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-042371","article-title":"Periprosthetic fractures: the next fragility fracture epidemic? A national observational study","volume":"10","author":"Bottle","year":"2020","journal-title":"BMJ Open"},{"issue":"9S2","key":"10.1016\/j.jocd.2025.101628_bib0082","doi-asserted-by":"crossref","first-page":"S454","DOI":"10.1016\/j.arth.2024.06.038","article-title":"Periprosthetic fractures: a rising tide of hip arthroplasty failure noted in the American joint replacement registry and the preventative role of cemented stems","volume":"39","author":"Sassoon","year":"2024","journal-title":"J Arthroplast"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0083","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11657-021-01055-9","article-title":"Prevalence and treatment rate of osteoporosis in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis","volume":"17","author":"Xiao","year":"2022","journal-title":"Arch Osteoporos"},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0084","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0286110","article-title":"Prevalence of osteoporosis in spinal surgery patients older than 50 years: a systematic review and meta-analysis","volume":"18","author":"Fan","year":"2023","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0085","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1038\/s41598-023-34230-8","article-title":"Evaluation of FRAX in patients with periprosthetic fractures following primary total hip and knee arthroplasty","volume":"13","author":"Holzer","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0086","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00198-024-07057-w","article-title":"Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis","volume":"35","author":"Whiting","year":"2024","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0087","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1016\/j.arth.2024.06.002","article-title":"Systemic osteoporosis and osteopenia among periprosthetic fractures after total hip arthroplasty","volume":"39","author":"Seward","year":"2024","journal-title":"J Arthroplast"},{"issue":"7S","key":"10.1016\/j.jocd.2025.101628_bib0088","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.arth.2023.03.031","article-title":"Frank Stinchfield award: creation of a patient-specific total hip arthroplasty periprosthetic fracture risk calculator","volume":"38","author":"Wyles","year":"2023","journal-title":"J Arthroplast"},{"issue":"7 Suppl 2","key":"10.1016\/j.jocd.2025.101628_bib0089","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.arth.2023.02.043","article-title":"The association of prior fragility fractures on 8-year periprosthetic fracture risk following total hip arthroplasty","volume":"38","author":"Zhao","year":"2023","journal-title":"J Arthroplast"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0090","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00223-024-01237-w","article-title":"Patients with periprosthetic femoral hip fractures are commonly classified as having osteoporosis based on DXA measurements","volume":"115","author":"Ritter","year":"2024","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0091","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00198-025-07385-5","article-title":"Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020","volume":"36","author":"Durbin","year":"2025","journal-title":"Osteoporos Int"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0092","doi-asserted-by":"crossref","first-page":"ziae070","DOI":"10.1093\/jbmrpl\/ziae070","article-title":"Celebrating 50-years: the history and future of the International Society of Bone Morphometry","volume":"8","author":"Scheller","year":"2024","journal-title":"JBMR Plus"},{"issue":"983","key":"10.1016\/j.jocd.2025.101628_bib0093","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/206489a0","article-title":"Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling","volume":"206","author":"Hattner","year":"1965","journal-title":"Nature"},{"key":"10.1016\/j.jocd.2025.101628_bib0094","series-title":"Osteoporosis","first-page":"1835","article-title":"Lessons from bone histomorphometry on the mechanism of action of osteoporosis drugs","author":"Zhou","year":"2021"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0095","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1359\/JBMR.040710","article-title":"Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients","volume":"19","author":"Recker","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"10117","key":"10.1016\/j.jocd.2025.101628_bib0096","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(17)32137-2","article-title":"Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"391","author":"Kendler","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0097","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1359\/JBMR.041114","article-title":"Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling","volume":"20","author":"Riggs","year":"2005","journal-title":"J Bone Miner Res"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0098","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jbmr.4243","article-title":"Early effects of abaloparatide on bone formation and resorption indices in postmenopausal women with osteoporosis","volume":"36","author":"Dempster","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0099","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jbmr.3309","article-title":"Remodeling- and modeling-based bone formation with teriparatide versus denosumab: a longitudinal analysis from baseline to 3 months in the AVA study","volume":"33","author":"Dempster","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0100","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.4457","article-title":"Modeling-based bone formation after 2 months of romosozumab treatment: results from the FRAME clinical trial","volume":"37","author":"Eriksen","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0101","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jbmr.3735","article-title":"Bone-forming and antiresorptive effects of romosozumab in postmenopausal women with osteoporosis: bone histomorphometry and microcomputed tomography analysis after 2 and 12 months of treatment","volume":"34","author":"Chavassieux","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0102","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","article-title":"Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis","volume":"103","author":"Dempster","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.jocd.2025.101628_bib0103","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jbmr.4006","article-title":"Modeling-based bone formation in the human femoral neck in subjects treated with denosumab","volume":"35","author":"Dempster","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.jocd.2025.101628_bib0104","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-E","article-title":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis","volume":"94","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.jocd.2025.101628_bib0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650090802","article-title":"The diagnosis of osteoporosis","volume":"9","author":"Kanis","year":"1994","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0106","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S2213-8587(24)00225-0","article-title":"Osteopenia: a key target for fracture prevention","volume":"12","author":"Reid","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jocd.2025.101628_bib0107","series-title":"Physician's Guide to Prevention and Treatment of Osteoporosis","year":"1998"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0108","first-page":"363","article-title":"Assessment of fracture risk with FRAX and FRAXplus","volume":"160","author":"Tan","year":"2024","journal-title":"Gac Med Mex"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0109","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11914-025-00909-2","article-title":"Sequential and long-term therapy for osteoporosis","volume":"23","author":"McClung","year":"2025","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0110","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0111","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13697137.2021.1953463","article-title":"Osteoanabolic therapy for osteoporosis in women","volume":"25","author":"McClung","year":"2022","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0112","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa2407031","article-title":"Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age","volume":"392","author":"Bolland","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0113","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1097\/BOT.0000000000002515","article-title":"An evaluation of treatment patterns for osteoporosis and outcomes after a fragility fracture in a real-world setting","volume":"37","author":"Singer","year":"2023","journal-title":"J Orthop Trauma"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0114","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0115","doi-asserted-by":"crossref","first-page":"e868","DOI":"10.1210\/clinem\/dgae659","article-title":"Approach to the patient: normocalcemic primary hyperparathyroidism","volume":"110","author":"Liu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0116","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0117","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00198-021-05966-8","article-title":"Fracture risk in hypoparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Pal","year":"2021","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0118","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/clinem\/dgae693","article-title":"Efficacy and safety of TransCon PTH in adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway trial","volume":"110","author":"Clarke","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0119","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bone.2012.11.045","article-title":"Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis","volume":"53","author":"Henriksen","year":"2013","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.jocd.2025.101628_bib0120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jbmr\/zjae057","article-title":"Oral daily PTH(1-34) tablets (EB613) in postmenopausal women with low BMD or osteoporosis: a randomized, placebo-controlled, 6-month, phase 2 study","volume":"39","author":"Tripto-Shkolnik","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"11","key":"10.1016\/j.jocd.2025.101628_bib0121","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41436-021-01242-6","article-title":"Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Manickam","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jocd.2025.101628_bib0122","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1523737","article-title":"Unraveling the complexity of skeletal dysplasias in the national health system","volume":"16","author":"Najjar","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jocd.2025.101628_bib0123","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae163.358","article-title":"Assessing the efficacy and safety of setrusumab for osteogenesis imperfecta: updated phase 2 data from the phase 2\/3 Orbit study","volume":"8","author":"Gottesman","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0124","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00198-023-06844-1","article-title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","volume":"35","author":"Khan","year":"2024","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jocd.2025.101628_bib0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00198-023-06859-8","article-title":"The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance","volume":"35","author":"Brandi","year":"2024","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-023-06843-2","article-title":"Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group","volume":"35","author":"Rush","year":"2024","journal-title":"Osteoporos Int"},{"issue":"5","key":"10.1016\/j.jocd.2025.101628_bib0127","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.11.019","article-title":"Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study","volume":"6","author":"Savarirayan","year":"2025","journal-title":"Med"},{"key":"10.1016\/j.jocd.2025.101628_bib0128","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102258","article-title":"Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"65","author":"Savarirayan","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.jocd.2025.101628_bib0129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa2411790","article-title":"Oral infigratinib therapy in children with achondroplasia","volume":"392","author":"Savarirayan","year":"2025","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jocd.2025.101628_bib0130","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jbmr.4315","article-title":"INZ-701 prevents ectopic tissue calcification and restores bone architecture and growth in ENPP1-deficient mice","volume":"36","author":"Cheng","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0131","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1038\/s41591-023-02561-8","article-title":"Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"29","author":"Di Rocco","year":"2023","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.jocd.2025.101628_bib0132","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/jbmr.4655","article-title":"Palovarotene for fibrodysplasia ossificans progressiva (FOP): results of a randomized, placebo-controlled, double-blind phase 2 trial","volume":"37","author":"Pignolo","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101550","article-title":"Bone health ECHO case report: is it Paget's disease?","volume":"28","author":"Cohen","year":"2025","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0134","article-title":"Bone health ECHO case report: normocalcemic hyperparathyroidism in a patient with osteoporosis referred for pre-operative bone health evaluation before spine surgery","volume":"28","author":"D'Annibale","year":"2025","journal-title":"J Clin Densitom"},{"issue":"4","key":"10.1016\/j.jocd.2025.101628_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101519","article-title":"Bone health ECHO case report: orbital inflammation after zoledronate infusion","volume":"27","author":"D'Annibale","year":"2024","journal-title":"J Clin Densitom"},{"issue":"2","key":"10.1016\/j.jocd.2025.101628_bib0136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101478","article-title":"Bone health ECHO case report: fractures and hypercalcemia in a patient with stage 5 chronic kidney disease","volume":"27","author":"Lewiecki","year":"2024","journal-title":"J Clin Densitom."},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0137","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101551","article-title":"Bone health ECHO case report: significant elevation in bone turnover markers and progression of vertebral fractures after denosumab discontinuation followed by a PTH-analog","volume":"28","author":"Kushchayeva","year":"2024","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0138","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101554","article-title":"Bone health ECHO case report: high bone mass in a patient with chronic kidney disease","volume":"28","author":"Belaya","year":"2024","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jocd.2025.101628_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2024.101552","article-title":"Bone health ECHO case report: rare cases of hypophosphatemia and low-traumatic fractures in patients with type 1 diabetes mellitus","volume":"28","author":"Belaya","year":"2024","journal-title":"J Clin Densitom"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695025000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695025000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:25:45Z","timestamp":1773296745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094695025000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":139,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1094695025000678"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2025.101628","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proceedings of the 2025 Santa Fe Bone Symposium: Current concepts in the care of patients with osteoporosis, parathyroid disorders, and rare bone diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2025.101628","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry.","name":"copyright","label":"Copyright"}],"article-number":"101628"}}